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Shared decision making after severe stroke- how can we improve patient and family involvement 
in treatment decisions?  
Involving patients and their families in making decisions about the treatments they receive after a 
severe stroke can help them achieve outcomes that are most acceptable to them. In this article, we 
offer ideas for improving decision making after stroke, drawing on current evidence in various 
patient groups and highlighting where further research is needed.  
 
Abstract 
People who are well may regard survival with disability as being worse than death. However, this is 
often not the case when those surviving with disability (e.g. stroke survivors) are asked the same 
question. Many routine treatments provided after an acute stroke (e.g. feeding via a tube) increase 
survival, but with disability. Therefore, clinicians need to support patients and families in making 
informed decisions about the use of these treatments, in a process termed shared decision-making. 
This is challenging after acute stroke: there is prognostic uncertainty, patients are often too unwell 
to participate in decision-making, and proxies may not know the patients’ expressed wishes (i.e. 
values). Patients’ values also change over time and in different situations. There is limited evidence 
on successful methods to facilitate this process. Changes targeted at components of shared decision-
making (e.g. decision aids to provide information and discussing patient values) increase patient 
satisfaction. How this influences decision-making is unclear. Presumably, a ‘shared decision-making 
tool’ that introduces effective changes at various stages in this process might be helpful after acute 
stroke. For example, by complementing professional judgement with predictions from prognostic 
models, clinicians could provide information that is more accurate. Decision aids that are 
personalised may be helpful. Further qualitative research can provide clinicians with a better 
understanding of patient values and factors influencing this at different time points after a stroke. 
The evaluation of this tool in its success to achieve outcomes consistent with patients’ values may 
require more than one clinical trial.  
 
Main text 
Many people who are well regard survival with severe disability to be worse than death.(1) 
However, when people with severe disability (.e.g., stroke survivors) are asked whether death is 
better than severe disability, they usually answer: ‘no’.(2) Decision making in the setting of acute 
stroke is particularly challenging because a severely affected patient may not be able to answer as 
their previously well self or their disabled future self. 
Shared decision-making is a dynamic process in which patients and clinicians share information, 
express treatment preferences and agree decisions. This is a gold standard in clinical care. Yet there 
is limited evidence on successful methods to facilitate this process. (3) To date, there are no trials 
evaluating shared decision-making on treatments after stroke. However, the effect of decision aids 
on information provision, a step towards shared decision-making, increases patient knowledge and 
satisfaction in various patient groups including stroke (4).  




Sensible decisions are made with knowledge about likely outcomes with different treatment 
strategies and knowledge about a patient’s wishes for the future (i.e. patient values). (5) We know 
this from studies on patients with multiple sclerosis(6) and in geriatrics.(7) 
How information provision and eliciting patient values impacts on decision-making remains unclear. 
Ideally, we want to develop a tool that targets several components of the shared decision-making 
process that is successful in helping patients achieve outcomes in keeping with their values.  To do 
this, we need to understand the challenges to adopting this process after stroke.  
Firstly, there is considerable statistical and clinical uncertainty about prognosis after stroke.(8) 
Providing information that is uncertain may hinder patients and families when making decisions 
about the appropriateness of treatments.  
Secondly, individuals place different values on different outcomes after stroke. This is because 
different outcomes (e.g. ability to talk, walk) may impact differently on different individuals’ quality 
of life. Many factors can affect this including culture and religion. (9)  
Thirdly, it may be difficult to elicit patient values after a stroke, and be certain of the accuracy of 
previously expressed wishes. This is because, those severely affected from their stroke may have 
dysphasia or cognitive impairments, preventing them from communicating their values. In these 
circumstances, clinicians often rely on proxies who may not know the patient’s values well. Even 
where a patient has expressed a previous wish, this may change over time (2) or when faced with 
the reality. For example, healthy people versus those who survived but were disabled after 
hemicraniectomy had differing views on survival with disability. (1) (2)  
There are a number of key decisions about treatments after stroke. Some reduce both mortality and 
long-term disability such as thrombectomy. (10) However, routine treatments like tube feeding (11) 
increase the chance of survival with disability. Given that different individuals place different values 
on different outcomes, it is crucial that patients and families are intimately involved in making 
decisions about the use of these treatments.  
To do this, more guidance is required. Firstly, clinicians need to be able to provide accurate 
information on prognosis. This may require clinicians to complement their professional judgement 
with predictions from prognostic models. Existing models that predict outcome after stroke have 
high specificity for survival or very poor outcome only. (8) Models that predict recovery of functions 
(e.g. mobility, speech) updated with data on early patient progress (e.g. early infection, continence) 
could improve accuracy of predictions. (12) 
Secondly, decision aids that are personalised could help information provision. In the development 
of a decision aid for thrombolysis after acute stroke, patients and relatives emphasised that 
information should be framed positively (e.g. independence rather than dependence). (13) 
Presenting information in different formats adapted to specific impairments (e.g. aphasia) using 
visually attractive methods (e.g. coloured charts) also aided clarity and relevance.(13) 
Thirdly, clinicians need to gain a better understanding of individual patient’s values for possible 
outcomes after stroke and factors influencing this. By encouraging patients and families to bring 
agendas to clinical meetings, clinicians have an opportunity to gain insight into factors affecting 
decision-making. Further qualitative research (e.g. by interviewing stroke survivors and their families 
over time) can provide an awareness into patient values pre- and post-stroke, changes over time and 
factors affecting decisions. Although the generalisability of such information is potentially 




challenging, the information gained would be invaluable to clinicians discussing appropriateness of 
treatments after severe stroke.  
To summarise, practising shared decision-making on treatments after severe stroke can be 
challenging. We recommend the development of a tool that incorporates changes at various stages 
in this process. Evaluation of this may require more than one clinical trial.  
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